Pang‐Dian Fan

2.0k citations
25 papers · 1.3k indexed · 1 hit paper · h-index 15
Topics
Lung Cancer Treatments and Mutations (12 papers)HER2/EGFR in Cancer Research (10 papers)Lung Cancer Research Studies (5 papers)
Partner nations
United StatesJapanSpain

In The Last Decade

Pang‐Dian Fan

25 papers receiving 1.2k citations

Hit Papers

Response to MET Inhibitors in Patients with Stage IV Lung...20152026201820222015100200300400

Peers

Pang‐Dian Fan
Comparison fields: 5 of 74
  • Pulmonary and Respiratory Medicine 679
  • Oncology 617
  • Molecular Biology 596
  • Cancer Research 276
  • Hepatology 113
Replace Rajani Kanteti with:
Rajani Kanteti United States
Ruth Riisnaes United Kingdom
Rajiv Bassi United States
Gayatry Mohapatra United States
Ulrike Tontsch-Grunt Austria
C. Martin Curtis United States
Shigeki Nanjo Japan
Analía Azaro Spain
Xenia Jimenez United States
Sanjay Koul United States
Pang‐Dian Fan relative to Rajani Kanteti United States Rajani Kanteti's profile →
Citations per field
00.5×2.5×
Rajani Kanteti · 1×
Citations per year

Countries citing papers authored by Pang‐Dian Fan

Since Specialization
Citations

This map shows the geographic impact of Pang‐Dian Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pang‐Dian Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pang‐Dian Fan more than expected).

Fields of papers citing papers by Pang‐Dian Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pang‐Dian Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pang‐Dian Fan. The network helps show where Pang‐Dian Fan may publish in the future.

Co-authorship network of co-authors of Pang‐Dian Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Pang‐Dian Fan. A scholar is included among the top collaborators of Pang‐Dian Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pang‐Dian Fan. Pang‐Dian Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 5
5 22
6 21
7 6
8 11
9 5
10 20
11
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skippingbreakdown →
423
12 29
13 60
14 353
15
Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
22
16 60
17 50
18 17
19 83
20 16

About Pang‐Dian Fan

Pang‐Dian Fan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (617 citations), Pulmonary and Respiratory Medicine (679 citations) and Cancer Research (276 citations). Pang‐Dian Fan has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Katerina Politi, Harold Varmus, Maureen F. Zakowski, Emily Schonfeld, William Pao, Helena A. Yu, Marc Ladanyi, Paul K. Paik, Charles M. Rudin and Stephen P. Goff. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026